Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gouteng Xuanshen, also known as the Gouteng Xuanshen Prescription or GouTengXuanShen KeLi, is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for its antihypertensive properties. The formulation is composed of botanical extracts including *Uncaria rhynchophylla* (Gouteng), *Scrophularia ningpoensis* (Xuanshen), and *Raphani Semen* (Radish Seed). It is traditionally indicated for patients with hypertension or prehypertension presenting with Liver Yang Syndrome. The formula is typically administered as granules (KeLi) and has been the subject of retrospective cohort studies and clinical trials conducted by the Affiliated Hospital of Shandong University of Traditional Chinese Medicine to evaluate its efficacy in lowering blood pressure and managing high normal blood pressure levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gouteng + xuanshen.